These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10836126)

  • 1. Laboratory of Chemical Pharmacology, National Heart, Lung, and Blood Institute, NIH: a short history.
    Gillette JR
    Annu Rev Pharmacol Toxicol; 2000; 40():18-41. PubMed ID: 10836126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology education and training at the National Institutes of Health.
    Lertora JJ; Atkinson AJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):907-9. PubMed ID: 17429349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of cytochrome P450 in the activation of drugs (author's transl)].
    Ullrich V
    Arzneimittelforschung; 1977; 27(96):1821-7. PubMed ID: 579147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-chemical research in phase I of drug testing in humans].
    Wolf HP
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1629-31. PubMed ID: 4801609
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds.
    Gillette JR
    Drug Metab Rev; 1979; 10(1):59-87. PubMed ID: 118860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences-National Research Council.
    Clin Pharmacol Ther; 1969; 10(5):607-34. PubMed ID: 4980111
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.
    Masubuchi Y; Horie T
    Crit Rev Toxicol; 2007 Jun; 37(5):389-412. PubMed ID: 17612953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory forum opinion piece: Tox21 and toxicologic pathology.
    Bucher JR
    Toxicol Pathol; 2013 Jan; 41(1):125-7. PubMed ID: 22692375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstetric clinical pharmacology: coming of age.
    Zajicek A; Giacoia GP
    Clin Pharmacol Ther; 2007 Apr; 81(4):481-2. PubMed ID: 17375105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
    Wada O; Yano Y
    Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
    [No Abstract]   [Full Text] [Related]  

  • 11. The intramural role of the NIH as a biomedical research institute.
    Narin F; Keith SB
    Fed Proc; 1978 Jun; 37(8):2120-3. PubMed ID: 658451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIH support of pharmacology.
    Munn JI
    Proc West Pharmacol Soc; 1968; 11():15-20. PubMed ID: 5757096
    [No Abstract]   [Full Text] [Related]  

  • 13. Interest of the National Heart Institute in comparative pharmacology.
    Stengle JM
    Fed Proc; 1967; 26(4):1162-3. PubMed ID: 6028778
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology-toxicology.
    Cosmides GJ
    Science; 1970 May; 168(3934):1013-4. PubMed ID: 5467456
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in the research landscape require a new approach, while continuing to fund the highest scientific priorities. Jennifer Taylor talks with Dr Elizabeth Nabel, Director of the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) National Library.
    Nabel E
    Eur Heart J; 2009 Jun; 30(12):1423-5. PubMed ID: 19533911
    [No Abstract]   [Full Text] [Related]  

  • 17. Opportunities for chemical biologists: a view from the National Institutes of Health.
    Berg JM
    ACS Chem Biol; 2006 Oct; 1(9):547-8. PubMed ID: 17168545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sun-downing and integration for the advancement of science and therapeutics: the National Institute on Substance Use Disorders (NISUD).
    Grabowski J
    Addiction; 2010 Dec; 105(12):2044-9. PubMed ID: 20712817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic mono-oxygenases].
    Robillart A; Zeisser M; Vailly B; Dupeyron JP
    Ann Fr Anesth Reanim; 1988; 7(2):149-55. PubMed ID: 3364813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [50 years of the Institute for Research in Pharmacy and Biochemistry].
    Trcka V
    Ceska Slov Farm; 2003 May; 52(3):107-14. PubMed ID: 12789769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.